Sutton Wealth Advisors Inc. Organogenesis Holdings Inc. Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$1.89 - $2.93 $7,342 - $11,383	-3,885 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$2.48 - $3.43 $3,315 - $4,585	1,337 Added 52.47%	3,885 $10.5 Million
Q3 2022 Nov 07, 2023	BUY	$3.14 - $6.43 $7,919 - $16,216	2,522 Added 9700.0%	2,548 $8.26 Million
Q2 2022 Nov 07, 2023	SELL	$4.74 - $8.15 $6,365 - $10,945	-1,343 Reduced 98.1%	26 $127,000
Q1 2022 Nov 07, 2023	BUY	$6.47 - $9.57 $2,982 - $4,411	461 Added 50.77%	1,369 $10.4 Million
Q4 2021 Nov 07, 2023	BUY	$9.02 - $13.5 $3,075 - $4,603	341 Added 60.14%	908 $8.39 Million
Q3 2021 Nov 07, 2023	BUY	$13.71 - $17.18 $397 - $498	29 Added 5.39%	567 $8.07 Million
Q2 2021 Nov 07, 2023	BUY	$14.92 - $23.23 $8,026 - $12,497	538 New	538 $8.94 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $399M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.